Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Clinical & Surgical Translation of Adult Stem Cells

Oren Levy's Biography



Oren Levy, Instructor of Medicine, Harvard Medical School/Brigham and Women’s Hospital

Dr. Oren Levy received his B.Sc. degree in Biology from Ben Gurion University (BGU), Israel. He carried out his M.Sc. and PhD research in BGU, focusing on key signaling pathways and their involvement in human mesenchymal stem cells (MSC) biology. Dr. Levy then joined the lab of Dr. Jeffrey Karp at Harvard Medical School/Brigham and Women’s Hospital as a postdoctoral research fellow. During his postdoctoral research, he focused on developing bio-engineering techniques to improve MSC homing to disease sites following transplantation to improve their therapeutic impact. Currently, as Instructor of Medicine at Harvard Medical School, Dr. Levy is focused on developing strategies to advance targeted cell-based drug delivery.

Oren Levy Image

Bio-engineering Strategies to Augment the Clinical Efficacy of Cell-based Therapies

Monday, 9 November 2015 at 11:40

Add to Calendar ▼2015-11-09 11:40:002015-11-09 12:40:00Europe/LondonBio-engineering Strategies to Augment the Clinical Efficacy of Cell-based TherapiesClinical and Surgical Translation of Adult Stem Cells in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

This talk will focus on novel bioengineering strategies aimed at maximizing the impact of stem cell therapies by enhancing the control over cell fate following transplantation. Specifically, approaches to control cell targeting to sites of disease to maximize therapeutic impact will be discussed. These include mRNA cell engineering to enable cell-based delivery of biologics to sites of inflammation, a multi-step screening platform to identify compounds that improve homing of systemically infused cells and a biomaterials-based platform to facilitate active cell-based targeting of therapeutics to sites of cancer. Overall, this talk will highlight the potential of harnessing cutting-edge bioengineering strategies to advance cell-based therapies.


Add to Calendar ▼2015-11-09 00:00:002015-11-10 00:00:00Europe/LondonClinical and Surgical Translation of Adult Stem CellsClinical and Surgical Translation of Adult Stem Cells in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com